Mentioned in this article
Overall market sentiment has been down on Aspira Women’s Health Inc (AWH) stock lately. AWH receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock’s trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver‘s Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What’s Happening With AWH Stock Today?
Aspira Women’s Health Inc (AWH) stock is trading at $0.41 as of 11:20 AM on Friday, Feb 24, a decline of -$0.05, or -9.89% from the previous closing price of $0.46. The stock has traded between $0.40 and $0.48 so far today. Volume today is elevated. So far 409,379 shares have traded compared to average volume of 277,308 shares.
More About Aspira Women’s Health Inc
Aspira Womens Health Inc is transforming women’s health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Click Here to get the full Stock Report for Aspira Women’s Health Inc stock.
You May Also Like
